SEC form 20-F/A, Exhibit 4.64 (filed 4/14) allows Par to release it's own generic focalin
all they need is agreement with manufacturer of branded drug
it's right there for all you pumpers to read, provided you can put down the pompoms long enough
question -- who always claims it is a conspiracy or some skullduggery whenever the stock goes down but never when it goes up?
answer -- this board's resident resolute cheerleaders who refuse to believe inconvenient truths
it's all there in ipci's filings with the SEC -- the reasons why institutions have been dumping (over 2 million shares last qtr) and shorts have been climbing aboard and insiders have not bought a single share -- it's all there for all who do not choose to be willfully ignorant
and, revenue sharing is NOT specified for ipci -- indeed, the filing acknowledges Par was already working on its own version using different technology and that Par is entitled to proceed
newbies, do not believe the creative pompom pumping nonsense that spews from the self-serving cheerleaders of this board